Eagle Pharmaceuticals
EGRX
#9801
Rank
โ‚ฌ9.21 M
Marketcap
0,71ย โ‚ฌ
Share price
-11.76%
Change (1 day)
-91.99%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : โ‚ฌ0.14 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚ฌ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.16 B135.8%
2021-12-31โ‚ฌ68.23 M24.94%
2020-12-31โ‚ฌ54.61 M-18.83%
2019-12-31โ‚ฌ67.28 M-1.11%
2018-12-31โ‚ฌ68.04 M-10.2%
2017-12-31โ‚ฌ75.77 M26.32%
2016-12-31โ‚ฌ59.98 M91.43%
2015-12-31โ‚ฌ31.33 M
2014-09-30โ‚ฌ16 M34.61%
2013-09-30โ‚ฌ11.89 M-29%
2012-09-30โ‚ฌ16.74 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ102.50 B 70,673.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.58 B 38,964.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ56.95 B 39,225.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ33.53 B 23,053.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ79.02 B 54,458.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ58.09 B 40,013.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ72.49 B 49,951.71%๐Ÿ‡บ๐Ÿ‡ธ USA